{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:22:09Z","timestamp":1760980929808,"version":"3.41.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1993,2,1]],"date-time":"1993-02-01T00:00:00Z","timestamp":728524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1993,2,1]],"date-time":"1993-02-01T00:00:00Z","timestamp":728524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm Gen Sect"],"published-print":{"date-parts":[[1993,2]]},"DOI":"10.1007\/bf02260911","type":"journal-article","created":{"date-parts":[[2005,11,23]],"date-time":"2005-11-23T02:48:12Z","timestamp":1132714092000},"page":"17-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Monoamine metabolism in the cerebrospinal fluid in Parkinson's disease: relationship to clinical symptoms and subsequent therapeutic outcomes"],"prefix":"10.1007","volume":"5","author":[{"given":"H.","family":"Tohgi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Nozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1993,2,1]]},"reference":[{"key":"BF02260911_CR1","first-page":"21","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1987","unstructured":"American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd ed, revised. APA, Washington DC, pp 21\u201323","edition":"3rd ed"},{"key":"BF02260911_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington: clinical morphological and neurochemical correlations. J Neurol Sci 20: 415\u2013455","journal-title":"J Neurol Sci"},{"key":"BF02260911_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2165\/00003088-197601050-00001","volume":"1","author":"JR Bianchine","year":"1976","unstructured":"Bianchine JR, Shaw GM (1976) Clinical pharmacokinetics of levodopa in Parkinson's disease. Clin Pharmacokinet 1: 313\u2013338","journal-title":"Clin Pharmacokinet"},{"key":"BF02260911_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0304-3940(78)90153-2","volume":"7","author":"A Bj\u00f6rklund","year":"1978","unstructured":"Bj\u00f6rklund A, Divac I, Lindvall O (1978) Regional distribution of catecholamines in monkey cerebral cortex, evidence for a dopaminergic innervation of the primate prefrontal cortex. Neurosci Lett 7: 115\u2013119","journal-title":"Neurosci Lett"},{"key":"BF02260911_CR5","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0140-6736(72)92566-4","volume":"ii","author":"MB Bowers Jr","year":"1972","unstructured":"Bowers MB Jr, Van Woert MH (1972) The probenecid test in Parkinson's disease. Lancet ii: 926\u2013927","journal-title":"Lancet"},{"key":"BF02260911_CR6","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1212\/WNL.40.7.1134","volume":"40","author":"T Brannan","year":"1990","unstructured":"Brannan T, Bhardwaj A, Yahr MD (1990) L-threodops increases extracellular norepinephrine levels in the brain: an in vivo study. Neurology 40: 1134\u20131135","journal-title":"Neurology"},{"key":"BF02260911_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1136\/jnnp.47.5.454","volume":"47","author":"RG Brown","year":"1984","unstructured":"Brown RG, Marsden CD, Quinn N, Wyke MA (1984) Alterations in cognitive performance and affect arousal state during fluctuations in motor function in Parkinson's disease. J Neurol Neurosurg Psychiatry 47: 454\u2013465","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02260911_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1001\/archneur.1972.00490180022006","volume":"27","author":"TN Chase","year":"1972","unstructured":"Chase TN, Ng LK (1972) Central monoamine metabolism in Parkinson's disease. Arch Neurol 27: 486\u2013491","journal-title":"Arch Neurol"},{"key":"BF02260911_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1017\/S0317167100044553","volume":"10","author":"L Cunha","year":"1983","unstructured":"Cunha L, Goncalves AF, Oliveira C, Dinis M, Amaral R (1983) Homovanillic acid in the cerebrospinal fluid of parkinsonian patients. Can J Neurol Sci 10: 43\u201346","journal-title":"Can J Neurol Sci"},{"key":"BF02260911_CR10","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/BF01485901","volume":"38","author":"H Ehringer","year":"1960","unstructured":"Ehringer H, Hornykiewicz O (1960) Verteilung von Noradrenalin und Dopamin (3-hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin Wochenschr 38: 1236\u20131239","journal-title":"Klin Wochenschr"},{"key":"BF02260911_CR11","first-page":"178","volume-title":"Advances in parkinsonism","author":"IJ Farley","year":"1976","unstructured":"Farley IJ, Hornykiewicz O (1976) Noradrenaline in subcortical brain regions of patients with Parkinson's disease and control subjects. In: Birkmayer W, Hornykiewicz O (eds) Advances in parkinsonism. Roche, Basel, pp 178\u2013185"},{"key":"BF02260911_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0166-2236(84)80145-9","volume":"7","author":"J Glowinski","year":"1984","unstructured":"Glowinski J, Tassin JP, Thierry AM (1984) The mesocortico-prefrontal dopaminergic neurons. Trends Neurosci 7: 415\u2013418","journal-title":"Trends Neurosci"},{"key":"BF02260911_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(69)91417-2","volume":"ii","author":"RB Godwin-Austen","year":"1969","unstructured":"Godwin-Austen RB, Frears CC, Tomlinson EB, Kok HW (1969) Effects of L-dopa in Parkinson's disease. Lancet ii: 165\u2013168","journal-title":"Lancet"},{"key":"BF02260911_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0022-510X(73)90050-6","volume":"19","author":"J Gumpert","year":"1973","unstructured":"Gumpert J, Sharpe DM, Curzon G (1973) Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to L-dopa. J Neurol Sci 19: 1\u201312","journal-title":"J Neurol Sci"},{"key":"BF02260911_CR15","first-page":"965","volume":"16","author":"K Hasegawa","year":"1974","unstructured":"Hasegawa K, Inoue K, Moriya K (1974) A study on dementia scaling in the elderly. Clin Psychiatry 16: 965\u2013969 (in Japanese)","journal-title":"Clin Psychiatry"},{"key":"BF02260911_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonsim: onset, progression, and mortality. Neurology 17: 427\u2013442","journal-title":"Neurology"},{"key":"BF02260911_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1212\/WNL.22.1.15","volume":"22","author":"E Jequier","year":"1972","unstructured":"Jequier E, Dufresne JJ (1972) Biochemical investigations in patients with Parkinson's disease treated with L-dopa. Neurology 22: 15\u201321","journal-title":"Neurology"},{"key":"BF02260911_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/mds.870010304","volume":"1","author":"HL Klawans","year":"1986","unstructured":"Klawans HL (1986) Individual manifestations of Parkinson's disease after ten or more years of levodopa. Mov Disord 1: 187\u2013192","journal-title":"Mov Disord"},{"key":"BF02260911_CR19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1001\/archneur.1986.00520020020009","volume":"43","author":"WC Koller","year":"1986","unstructured":"Koller WC (1986) Pharmacologic treatment of parkinsonian tremor. Arch Neurol 43: 126\u2013127","journal-title":"Arch Neurol"},{"key":"BF02260911_CR20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(71)92338-5","volume":"ii","author":"JP Lakke","year":"1971","unstructured":"Lakke JP, Korf J, van Praag HM (1971) Predicting response to levodopa. Lancet ii: 164\u2013165","journal-title":"Lancet"},{"key":"BF02260911_CR21","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979\u2013980","journal-title":"Science"},{"key":"BF02260911_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/brain\/106.2.257","volume":"106","author":"AJ Lees","year":"1983","unstructured":"Lees AJ, Smith E (1983) Cognitive deficits in the early stages of Parkinson's disease. Brain 106: 257\u2013270","journal-title":"Brain"},{"key":"BF02260911_CR23","first-page":"277","volume-title":"Ergot compounds and brain function. Neuropsychiatric aspects","author":"A Lieberman","year":"1980","unstructured":"Lieberman A, Dziatolowski M, Gopinathan G, Kupersmith K, Neophytides A, Korein J (1980) Evaluation of Parkinson's disease. In: Goldstein M, Calne DB, Lieberman AN, Thorner MO (eds) Ergot compounds and brain function. Neuropsychiatric aspects. Raven, New York, pp 277\u2013286"},{"key":"BF02260911_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0009-8981(77)90193-0","volume":"75","author":"T Nagatsu","year":"1977","unstructured":"Nagatsu T, Kato T, Numata Y, Sano M, Nagatsu I, Kondo Y, Inagaki S, Iizuka R, Hori A, Narabayashi H (1977) Phenylethanolamine N-methyl-transferase and other enzymes of catecholamine metabolism in human brain. Clin Chim Acta 75: 221\u2013232","journal-title":"Clin Chim Acta"},{"key":"BF02260911_CR25","first-page":"283","volume":"24","author":"T Nagatsu","year":"1979","unstructured":"Nagatsu T, Kato T, Nagatsu I, Kondo Y, Inagaki S, Iizuka R, Narabayashi H (1979) Catecholamine related enzymes in the brain of patients with parkinsonism and Wilson's disease. Adv Neurol 24: 283\u2013292","journal-title":"Adv Neurol"},{"key":"BF02260911_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2220\/biomedres.3.95","volume":"3","author":"T Nagatsu","year":"1982","unstructured":"Nagatsu T, Wakui Y, Kato T, Fujita K, Kondo T, Yokochi F, Narabayashi H (1982) Dopamine beta-hydroxylase activity in cerebrospinal fluid of Parkinsonian patients. Biomed Res 3: 95\u201398","journal-title":"Biomed Res"},{"key":"BF02260911_CR27","first-page":"279","volume-title":"Recent developments in Parkinson's disease, vol II","author":"H Narabayashi","year":"1987","unstructured":"Narabayashi H, Kondo T (1987) Results of a double-blind study of L-threo-DOPS in parkinsonism. In: Fahn S, et al (eds) Recent developments in Parkinson's disease, vol II. Macmillan, New Jersey, pp 279\u2013291"},{"issue":"Ser B","key":"BF02260911_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2183\/pjab.57.351","volume":"57","author":"H Narabayashi","year":"1981","unstructured":"Narabayashi H, Kondo T, Hayashi A, Suzuki T, Nagatsu T (1981) L-threo-3,4-dihydroxyphenylserine treatment for akinesia and freezing of parkinsonism. Proc Jpn Acad 57 (Ser B): 351\u2013354","journal-title":"Proc Jpn Acad"},{"key":"BF02260911_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/mds.870040112","volume":"4","author":"NP Quinn","year":"1989","unstructured":"Quinn NP, Luthert P, Honarar M, Marsden CD (1989) Pure akinesia due to Lewy body Parkinson's disease: a case with pathology. Mov Disord 4: 85\u201389","journal-title":"Mov Disord"},{"key":"BF02260911_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/BF01252019","volume":"41","author":"P Riederer","year":"1977","unstructured":"Riederer P, Birkmayer W, Seeman D, Wuketich S (1977) Brain-noradrenaline and 3-methoxy-hydroxyphenylglycol in Parkinson's syndrome. J Neural Transm 41: 241\u2013251","journal-title":"J Neural Transm"},{"key":"BF02260911_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0006-8993(83)90993-9","volume":"275","author":"B Scatton","year":"1983","unstructured":"Scatton B, Javoy-Agid F, Rouquier L, Dubois B, Agid Y (1983) Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res 275: 321\u2013328","journal-title":"Brain Res"},{"key":"BF02260911_CR32","first-page":"277","volume":"53","author":"H Tohgi","year":"1990","unstructured":"Tohgi H, Abe T, Takahashi S, Ueno M, Nozaki Y (1990a) Cerebrospinal fluid dopamine, norepinephrine, and epinephrine concentrations in Parkinson's disease correlated with clinical symptoms. Adv Neurol 53: 277\u2013282","journal-title":"Adv Neurol"},{"key":"BF02260911_CR33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/0304-3940(90)90409-3","volume":"116","author":"H Tohgi","year":"1990","unstructured":"Tohgi H, Abe T, Takahashi S, Takahashi J, Ueno M, Nozaki Y (1990b) Effect of a synthetic norepinephrine precursor, L-threo-3-4-dihydroxyphenylserine on the total norepinephrine concentration in the cerebrospinal fluid of parkinsonian patients. Neurosci Lett 116: 194\u2013197","journal-title":"Neurosci Lett"},{"key":"BF02260911_CR34","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1471-4159.1985.tb07149.x","volume":"49","author":"GM Tyce","year":"1985","unstructured":"Tyce GM, Rorie DK, Byer DE, Danielson DR (1985) Free and conjugated amines in human lumbar cerebrospinal fluid. J Neurochem 49: 322\u2013324","journal-title":"J Neurochem"},{"key":"BF02260911_CR35","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0140-6736(71)91409-7","volume":"i","author":"MH Van Woert","year":"1971","unstructured":"Van Woert MH, Weintraub MI (1971) Predicting the response to levodopa. Lancet i: 1015\u20131016","journal-title":"Lancet"},{"key":"BF02260911_CR36","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/jnnp.36.5.747","volume":"36","author":"WJ Weiner","year":"1973","unstructured":"Weiner WJ, Klawans HL Jr (1973) Failure of cerebrospinal fluid homovanillic acid to predict levodopa response in Parkinson's disease. J Neurol Neurosurg Psychiatry 36: 747\u2013752","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of Neural Transmission - Parkinson's Disease and Dementia Section"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02260911.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02260911\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02260911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02260911.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T03:37:17Z","timestamp":1750822637000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02260911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,2]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,2]]}},"alternative-id":["BF02260911"],"URL":"https:\/\/doi.org\/10.1007\/bf02260911","relation":{},"ISSN":["0936-3076"],"issn-type":[{"type":"print","value":"0936-3076"}],"subject":[],"published":{"date-parts":[[1993,2]]},"assertion":[{"value":"26 February 1992","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 1992","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 1993","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}